Rosa Gilabert

Rosa Gilabert

Auto-generated profile, based on publicly available information

Rosa Gilabert

Diagnostic Imaging Centre, IDIBAPS, Hospital Clínic , 149 Rosellon Road, Barcelona 08036

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Journal of Hepatology
Verified
Journal Article
Open access
FTFanny Turon
Fanny Turon
EDEllen G. Driever
Ellen G. Driever
ABAnna Baiges
Anna Baiges
ECEira Cerda
Eira Cerda
ÁGÁngeles García-Criado
Ángeles García-Criado
JGJuan Carlos García-Pagán
Juan Carlos García-Pagán
Portal vein thrombosis (PVT) is a relatively frequent event in patients with cirrhosis. While different risk factors for PVT have been reported, such as decreased portal blood flow velocity (PBFV) and parameters related with severity of portal hypertension, these are based on retrospective studies assessing only a discrete number of parameters. The aim of the current study was to evaluate the incidence and risks factors for non-tumoral PVT development in a large prospective cohort of patients with cirrhosis. We performed an exhaustive evaluation of clinical, biochemical, inflammatory and acquired/hereditary hemostatic profiles in 369 patients with cirrhosis without PVT who were prospectively followed-up. Doppler ultrasound was performed at baseline and every 6 months or whenever clinically indicated. PVT development was always confirmed by computed tomography. Twenty-nine patients developed non-tumoral PVT, with an incidence of 1.6%, 6% and 8.4% at 1, 3 and 5 years, respectively. Low platelet count, PBFV <15 cm/sec and history of variceal bleeding were factors independently associated with a high PVT risk. No relationship between PVT development and any other clinical biochemical, inflammatory and acquired or hereditary hemostatic parameter was found. In patients with cirrhosis, the factors predictive of PVT development were mainly those related to the severity of portal hypertension. Our results do not support the role of hemostatic alterations (inherited or acquired) and inflammatory markers in the prediction of PVT in patients with cirrhosis. Patients with cirrhosis and more severe portal hypertension are at higher risk of non-tumoral portal vein thrombosis development. Acquired or inherited hemostatic disorders, as well as inflammatory status, do not seem to predict the development of portal vein thrombosis in patients with cirrhosis.

5 November 2009 in Surgical and Radiologic Anatomy
Verified
Journal Article
Closed access
PDF file
XBXavier Bargalló
Xavier Bargalló
ACAnna Carrera
Anna Carrera
XSXavier Sala-Blanch
Xavier Sala-Blanch
GSGorane Santamaría
Gorane Santamaría
RMRosa Morro
Rosa Morro
RGRosa Gilabert
Rosa Gilabert

15 May 2023 in Clinical Nutrition
Verified
Journal Article
Open access
FBFrancesc Bujosa
Francesc Bujosa
ZHZoe Herreras
Zoe Herreras
MCMarta Catalán
Marta Catalán
MPMontse Pinyol
Montse Pinyol
RLRosa M. Lamuela-Raventos
Rosa M. Lamuela-Raventos
GCGemma Chiva-Blanch
Gemma Chiva-Blanch
Atherosclerosis is the major risk factor for cardiovascular disease (CVD), the first cause of death worldwide. Chronic low-grade inflammation and a sustained oxidative milieu are causatively related to atherosclerosis onset and progression, and therefore, dietary patterns rich in bioactive compounds with anti-inflammatory and antioxidant activities might likely contribute to revert or slowing the progression of atherosclerosis. The aim of this study is to analyse the association between fruit and vegetables intake, quantitatively measured through carotene plasma concentrations, and atherosclerotic burden, as a surrogate biomarker of CVD, in free-living subjects from the DIABIMCAP cohort study. The 204 participants of the DIABIMCAP Study cohort (Carotid Atherosclerosis in Newly Diagnosed Type 2 Diabetic Individuals, ClinicalTrials.gov Identifier: NCT01898572), were included in this cross-sectional study. Total, α-, and β-carotenes were quantified by HPLC-MS/MS. Lipoprotein analysis in serum was performed by 2D- 1H NMR- DOSY, and atherosclerosis and intima media thickness (IMT) were measured through standardized bilateral carotid artery ultrasound imaging. Subjects with atherosclerosis (n = 134) had lower levels of large HDL particles than subjects without atherosclerosis. Positive associations were found between α-carotene and both large and medium HDL particles, and inverse associations were found between β- and total carotene, and VLDL and its medium/small particles. Subjects with atherosclerosis presented significantly lower plasma concentrations of total carotene compared with subjects without atherosclerosis. Plasma concentrations of carotene decreased as the number of atherosclerotic plaques increased, although after multivariate adjustment, the inverse association between β- and total carotene with plaque burden remained significant only in women. A diet rich in fruit and vegetables results in higher plasmatic carotene concentrations, which are associated with a lesser atherosclerotic plaque burden.

1 June 2007 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
VRVicente Riambau
Vicente Riambau
FGFrancisco Guerrero
Francisco Guerrero
XMXavier Montañá
Xavier Montañá
RGRosa Gilabert
Rosa Gilabert

24 February 2025 in Cardiovascular Research
Verified
Journal Article
Open access
ARAna María Ruiz-León
Ana María Ruiz-León
MCMiguel Camafort
Miguel Camafort
ASAleix Sala-Vila
Aleix Sala-Vila
RGRosa Gilabert
Rosa Gilabert
INIsabel Núñez
Isabel Núñez
Rosa CasasRosa Casas
Rosa Casas

1 May 2008 in Atherosclerosis Supplements
Verified
Journal Article
Closed access
MJM. Junyent
M. Junyent
RGR. Gilabert
R. Gilabert
INI. Nunez
I. Nunez
MPM. Pocovi
M. Pocovi
MMM. Mallen
M. Mallen
EREmilio Ros
Emilio Ros